← Open Payments lookup

NPI 1811348824: Open Payments

NPI 1811348824. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$300 in 6 payments from 5 companies in 2025. Trend: 2023 $681 · 2024 $793 · 2025 $300

Food & beverage: $300
CompanyPaymentsAmount
Eisai Inc.2$142
Genentech USA, Inc.1$89
Biogen, Inc.1$27
ABBVIE INC.1$23
AstraZeneca Pharmaceuticals LP1$18

Products named: Leqembi, Ocrevus, UBRELVY, AIRSUPRA.